Barrons.com1d agobearish
Merck Delivers a Clean Earnings Beat on Oncology Strength. Is It Enough to Impress Wall Street?The drugmaker posts a narrower-than-expected quarterly loss fueled by growth in its oncology segment.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
542last 24h
2521last 7d
483● bullish (7d)
259● bearish (7d)
197publishers
Quartz5d agobearish
Moderna Q2 earnings beat estimates as norovirus vaccine stumblesThe company topped Wall Street loss estimates, but its norovirus vaccine missed a key trial goal, sending shares lower
Zacks15d agobearish
Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key InsightsIn the most recent trading session, Moderna (MRNA) closed at $59.49, indicating a -3.77% shift from the previous trading day.
Zacks22d agobearish
Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to NoteModerna (MRNA) reached $66.98 at the closing of the latest trading day, reflecting a -1.89% change compared to its last close.
Trefis23d agobearish
What It Means To Hold Moderna Stock In A CrashThe company's pipeline is more advanced than ever, but its history shows a pattern of deep, prolonged drops when the market turns.
24/7 Wall St.26d agobearish
Moderna Drops 11%, ImmunityBio and Sarepta Therapeutics Tumble 8% in Biotech RoutModerna, ImmunityBio, and Sarepta are all cratering today despite bullish recent news and no negative catalysts in sight, leaving investors scrambling to understand whether the biotech sector's monster 2026 run has finally hit a wall.
Proactive28d agobearish
Dow Jones and Nasdaq called lower as Trump says Iran ceasefire 'over'US stocks are expected to extend losses on Wednesday after oil prices spiked following an exchange of strikes between the US and Iran that led to President Donald Trump declaring the ceasefire "over". Dow Jones futures were down 1.1%, with S&P 500 futures pointing to a 0.9% drop, while...
Motley Fool32d agobearish
Moderna Is Up More Than 70% in a Month After a 9-0 FDA Vote. Wall Street's Average Price Target Says It Should Fall 44%. What Gives?When a stock and the analysts covering it disagree this sharply, one of them is about to be wrong.
MT Newswires39d agobearish
US Equity Markets End Lower Amid Technology Stocks Sell-OffUS equity indexes were lower on Friday amid a sell-off in technology stocks and despite a decline in
Motley Fool49d agobearish
Stock Market Today, June 16: Nvidia, Broadcom, and Micron Technology Lead Drop in NasdaqRetail investors reassess growth favorites as Robinhood’s job cuts ripple through a market tilting toward industrial and financial stocks, today, June 16, 2026.
StockStory51d agobearish
3 Stocks Under $50 That Fall ShortThe $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
BioPharma Dive71d agobearish
Astellas eyes more cost cuts; FDA panel to debate Moderna vaccineThe Japanese pharma is aiming for $1.3 billion in yearly savings between now and 2030. Elsewhere, Datroway gained a new clearance in breast cancer and the FDA approved a drug for hepatitis D.
Simply Wall St.71d agobearish
Litigation Windfall Driving Roivant Sciences’ Profit Swing Might Change The Case For Investing In Roivant Sciences (ROIV)In May 2026, Roivant Sciences reported fourth-quarter 2026 results showing sales of US$2.52 million, a swing to quarterly net income of US$302.99 million, and full-year 2026 sales of US$8.26 million alongside a wider annual net loss of US$299.77 million. The earnings were heavily influenced by a US$770.2 million litigation settlement gain linked to Genevant’s US$2.25 billion global patent settlement with Moderna, highlighting how non-operating items and asset monetization can meaningfully...
Simply Wall St.75d agobearish
Moderna (MRNA) Is Down 5.5% After FDA Sets Flu Vaccine Review, Tightens Lawsuit Venue Rules - What's ChangedOn May 6, 2026, Moderna’s board amended its bylaws to require Securities Act of 1933 lawsuits be filed exclusively in US federal district courts, aligning with recent Delaware law changes, while the FDA set a June 18 advisory panel review for the company’s mRNA-based seasonal flu vaccine after an earlier filing setback. Together with ongoing insider share sales under a preset trading plan and fresh real-world data on its pediatric COVID-19 vaccine effectiveness, these developments sharpen...
Barrons.com86d agobearish
Moderna Stock Jumps. U.S. Passenger on Hantavirus Cruise Ship Tests Positive.The U.S. health department said one passenger on a repatriation flight has tested mildly positive for the virus, while another is currently experiencing mild symptoms.